Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Repurposing an HIV Drug for Zika Virus Therapy.

Xie X, Shi PY.

Mol Ther. 2019 Dec 4;27(12):2064-2066. doi: 10.1016/j.ymthe.2019.10.004. Epub 2019 Oct 14. No abstract available.

PMID:
31624014
2.

Repurposing drugs for use against Zika virus infection.

Devillers J.

SAR QSAR Environ Res. 2018 Feb;29(2):103-115. doi: 10.1080/1062936X.2017.1411642. Epub 2018 Jan 4. Review.

PMID:
29299939
3.

Drug Repurposing: New Treatments for Zika Virus Infection?

Cheng F, Murray JL, Rubin DH.

Trends Mol Med. 2016 Nov;22(11):919-921. doi: 10.1016/j.molmed.2016.09.006. Epub 2016 Sep 28.

PMID:
27692879
4.

Can an FDA-Approved Alzheimer's Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?

Sirohi D, Kuhn RJ.

MBio. 2017 Jun 27;8(3). pii: e00916-17. doi: 10.1128/mBio.00916-17.

5.

Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection.

Veljkovic V, Paessler S.

Version 2. F1000Res. 2016 Feb 18 [revised 2016 Jan 1];5:190. doi: 10.12688/f1000research.8102.2. eCollection 2016.

6.

Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika.

Cao RY, Xu YF, Zhang TH, Yang JJ, Yuan Y, Hao P, Shi Y, Zhong J, Zhong W.

Open Forum Infect Dis. 2017 Feb 3;4(1):ofx009. doi: 10.1093/ofid/ofx009. eCollection 2017 Winter.

7.

The antimalarial drug amodiaquine possesses anti-ZIKA virus activities.

Han Y, Mesplède T, Xu H, Quan Y, Wainberg MA.

J Med Virol. 2018 May;90(5):796-802. doi: 10.1002/jmv.25031. Epub 2018 Feb 21.

PMID:
29315671
8.

Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update.

Han Y, Mesplède T.

Expert Opin Investig Drugs. 2018 Dec;27(12):951-962. doi: 10.1080/13543784.2018.1548609. Review.

PMID:
30430882
9.

Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.

Xu M, Lee EM, Wen Z, Cheng Y, Huang WK, Qian X, Tcw J, Kouznetsova J, Ogden SC, Hammack C, Jacob F, Nguyen HN, Itkin M, Hanna C, Shinn P, Allen C, Michael SG, Simeonov A, Huang W, Christian KM, Goate A, Brennand KJ, Huang R, Xia M, Ming GL, Zheng W, Song H, Tang H.

Nat Med. 2016 Oct;22(10):1101-1107. doi: 10.1038/nm.4184. Epub 2016 Aug 29.

10.

Small Molecules and Antibodies for Zika Therapy.

Xie X, Zou J, Shan C, Shi PY.

J Infect Dis. 2017 Dec 16;216(suppl_10):S945-S950. doi: 10.1093/infdis/jix406. Review.

11.

Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus.

Rausch K, Hackett BA, Weinbren NL, Reeder SM, Sadovsky Y, Hunter CA, Schultz DC, Coyne CB, Cherry S.

Cell Rep. 2017 Jan 17;18(3):804-815. doi: 10.1016/j.celrep.2016.12.068.

12.

Drugs for the Treatment of Zika Virus Infection.

Bernatchez JA, Tran LT, Li J, Luan Y, Siqueira-Neto JL, Li R.

J Med Chem. 2019 Oct 4. doi: 10.1021/acs.jmedchem.9b00775. [Epub ahead of print]

PMID:
31549836
13.

Placental Histopathology and Clinical Presentation of Severe Congenital Zika Syndrome in a Human Immunodeficiency Virus-Exposed Uninfected Infant.

Rabelo K, de Souza Campos Fernandes RC, de Souza LJ, Louvain de Souza T, Dos Santos FB, Guerra Nunes PC, de Azeredo EL, Salomão NG, Trindade GF, Basílio-de-Oliveira CA, de Carvalho JJ, Medina-Acosta E, Paes MV.

Front Immunol. 2017 Dec 7;8:1704. doi: 10.3389/fimmu.2017.01704. eCollection 2017.

14.

Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis.

Shiryaev SA, Mesci P, Pinto A, Fernandes I, Sheets N, Shresta S, Farhy C, Huang CT, Strongin AY, Muotri AR, Terskikh AV.

Sci Rep. 2017 Nov 17;7(1):15771. doi: 10.1038/s41598-017-15467-6.

15.

Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus.

Saiz JC, Oya NJ, Blázquez AB, Escribano-Romero E, Martín-Acebes MA.

Viruses. 2018 Aug 24;10(9). pii: E453. doi: 10.3390/v10090453. Review.

16.

Antiviral Agents in Development for Zika Virus Infections.

Baz M, Boivin G.

Pharmaceuticals (Basel). 2019 Jun 29;12(3). pii: E101. doi: 10.3390/ph12030101. Review.

17.

First detection of autochthonous Zika virus transmission in a HIV-infected patient in Rio de Janeiro, Brazil.

Calvet GA, Filippis AM, Mendonça MC, Sequeira PC, Siqueira AM, Veloso VG, Nogueira RM, Brasil P.

J Clin Virol. 2016 Jan;74:1-3. doi: 10.1016/j.jcv.2015.11.014. Epub 2015 Nov 23.

PMID:
26615388
18.

HIV and ZIKA in Pregnancy: Parallel Stories and New Challenges.

Zorrilla CD, Mosquera AM, Rabionet S, Rivera-Viñas J.

Obstet Gynecol Int J. 2016;5(6). pii: 180. doi: 10.15406/ogij.2016.05.00180. Epub 2016 Dec 15.

19.

Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden.

Bai JPF.

J Pharm Sci. 2016 Oct;105(10):3007-3012. doi: 10.1016/j.xphs.2016.07.004. Epub 2016 Aug 12. Review.

PMID:
27522921
20.

Stem Cell Hydrogel, Jump-Starting Zika Drug Discovery, and Engineering RNA Recognition.

Kostic M.

Cell Chem Biol. 2016 Aug 18;23(8):885-6. doi: 10.1016/j.chembiol.2016.08.005.

Supplemental Content

Support Center